Patient Education Resource: Non-Hodgkin Lymphoma — Clinical Experts Address Common Questions Posed by Patients About CAR T-Cell Therapy

<p class="MsoNormal">Featuring perspectives from <span class= "normaltextrun">Dr Jeremy S Abramson and Dr Manali Kamdar</span>, including the following topics: </p> <ul> <li class="MsoNormal">Introduction: About This Program (0:00)</li> <li>Overview of Chimeric Antigen Receptor (CAR) T-Cell Therapy (3:10)</li> <li class="MsoNormal">Potential Treatment Benefits of CAR T-Cell Therapy (10:35)</li> <li class="MsoNormal">CRS (Cytokine Release Syndrome) and ICANS (Immune Effector Cell-Associated Neurotoxicity Syndrome) (34:32)</li> <li class="MsoNormal">Finding Information About CAR T; Clinical Trials (42:17)</li> <li class="MsoNormal">Financial Issues; Risk of Infection (48:11)</li> <li>Coping with Anxiety; Healing and Moving On (55:17)</li> </ul> <p class="ghq-next-card-contentp"><a href= "http://m.researchtopractice.com/PatientProject2025/CARTPatients">Educational and presenter information</a></p>